Arak University of Medical Sciences

Services

Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib

22 August 2020 | 11:10 Code : 11252 New Features

visits:25720

http://http://journal.waocp.org/article_88725.html

Related News

Final Deadline for Obtaining the YEKTA Code and Registering for Basic Health Insurance

Final Deadline for Obtaining the YEKTA Code and Re...

This is to inform all esteemed students that the deadline for submitti...

Validity and reliability of the Persian version of the Eating and Drinking Ability Classification System

Validity and reliability of the Persian version of...

The Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF): A validation study in Iranian mothers

The Breastfeeding Self-Efficacy Scale-Short Form (...

Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017

Global, regional and national burden of rheumatoid...

http://https://ard.bmj.com/content/78/11/1463